Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up
The influence of pharmacotherapeutic follow-up (PTF) on quality of life was evaluated in 45 HIV+ patients, who were undergoing initial antiretroviral therapy at a specialized care center in northeast Brazil. PTF lasted nine months and quality of life was analyzed at the 1st and 9th meetings using a...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2012-12-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400015 |
id |
doaj-6436d68aa30747de8364811d96e9743b |
---|---|
record_format |
Article |
spelling |
doaj-6436d68aa30747de8364811d96e9743b2020-11-24T23:40:58ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences1984-82502175-97902012-12-01484711718Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-upCatarine Vitor LoureiroHenry Pablo Lopes Campos e ReisKarla do Nascimento MagalhãesCristiane Policarpo CarmoFrancisca Ana Maria LeiteAna Cláudia de Brito PassosPaulo Yuri Milen FirminoNadir KheirDavid John WoodsÂngela Maria de Souza PoncianoMarta Maria de França FontelesThe influence of pharmacotherapeutic follow-up (PTF) on quality of life was evaluated in 45 HIV+ patients, who were undergoing initial antiretroviral therapy at a specialized care center in northeast Brazil. PTF lasted nine months and quality of life was analyzed at the 1st and 9th meetings using a questionnaire validated for Brazil. The study identified 643 problems related to antiretrovirals and there were 590 pharmaceutical interventions during the PTF. The comparative analysis between the results of the 1st and the 9th meeting was statistically significant for all domains of the questionnaire. For asymptomatic patients, only one domain was statistically significant. For symptomatic patients, six domains were significant. Patients with one year of HIV/AIDS diagnosis had statistically significant differences in five domains. The results suggest that the PTF contributed to improving quality of life, particularly for symptomatic patients and those diagnosed for at least one year - important target groups for Pharmaceutical Treatment.<br>A influência do seguimento farmacoterapêutico (SFT) sobre a qualidade de vida foi avaliada em 45 pacientes HIV+ assistidos em serviço de atendimento especializado do nordeste brasileiro. O SFT teve duração de 9 meses e a qualidade de vida foi analisada no 1º e 9º encontros através de questionário validado no País. Identificaram-se 643 problemas relacionados aos antirretrovirais e realizaram-se 590 intervenções farmacêuticas durante o SFT. A análise comparativa entre os resultados de qualidade de vida do 1º e 9º encontro foi estatisticamente significativa em todos os domínios do questionário. Quando analisados somente os pacientes assintomáticos, apenas um domínio apresentou significância estatística. Entre os sintomáticos, seis domínios foram significativos. Pacientes com até um ano de diagnóstico de HIV/AIDS apresentaram validade estatística em cinco domínios. Os resultados sugerem que o SFT contribuiu para a melhoria da qualidade de vida dos pacientes, sobretudo dos sintomáticos e/ou com até um ano de diagnóstico, representando grupos-alvo para a prática da Atenção Farmacêutica.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400015Seguimento farmacoterapêuticoSeguimento farmacoterapêuticoPaciente de HIVAtenção FarmacêuticaPharmacotherapeutic follow-upPharmacotherapeutic follow-upHIV patientsPharmaceutical care |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Catarine Vitor Loureiro Henry Pablo Lopes Campos e Reis Karla do Nascimento Magalhães Cristiane Policarpo Carmo Francisca Ana Maria Leite Ana Cláudia de Brito Passos Paulo Yuri Milen Firmino Nadir Kheir David John Woods Ângela Maria de Souza Ponciano Marta Maria de França Fonteles |
spellingShingle |
Catarine Vitor Loureiro Henry Pablo Lopes Campos e Reis Karla do Nascimento Magalhães Cristiane Policarpo Carmo Francisca Ana Maria Leite Ana Cláudia de Brito Passos Paulo Yuri Milen Firmino Nadir Kheir David John Woods Ângela Maria de Souza Ponciano Marta Maria de França Fonteles Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up Brazilian Journal of Pharmaceutical Sciences Seguimento farmacoterapêutico Seguimento farmacoterapêutico Paciente de HIV Atenção Farmacêutica Pharmacotherapeutic follow-up Pharmacotherapeutic follow-up HIV patients Pharmaceutical care |
author_facet |
Catarine Vitor Loureiro Henry Pablo Lopes Campos e Reis Karla do Nascimento Magalhães Cristiane Policarpo Carmo Francisca Ana Maria Leite Ana Cláudia de Brito Passos Paulo Yuri Milen Firmino Nadir Kheir David John Woods Ângela Maria de Souza Ponciano Marta Maria de França Fonteles |
author_sort |
Catarine Vitor Loureiro |
title |
Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up |
title_short |
Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up |
title_full |
Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up |
title_fullStr |
Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up |
title_full_unstemmed |
Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up |
title_sort |
quality of life of hiv+ patients undergoing pharmacotherapeutic follow-up |
publisher |
Universidade de São Paulo |
series |
Brazilian Journal of Pharmaceutical Sciences |
issn |
1984-8250 2175-9790 |
publishDate |
2012-12-01 |
description |
The influence of pharmacotherapeutic follow-up (PTF) on quality of life was evaluated in 45 HIV+ patients, who were undergoing initial antiretroviral therapy at a specialized care center in northeast Brazil. PTF lasted nine months and quality of life was analyzed at the 1st and 9th meetings using a questionnaire validated for Brazil. The study identified 643 problems related to antiretrovirals and there were 590 pharmaceutical interventions during the PTF. The comparative analysis between the results of the 1st and the 9th meeting was statistically significant for all domains of the questionnaire. For asymptomatic patients, only one domain was statistically significant. For symptomatic patients, six domains were significant. Patients with one year of HIV/AIDS diagnosis had statistically significant differences in five domains. The results suggest that the PTF contributed to improving quality of life, particularly for symptomatic patients and those diagnosed for at least one year - important target groups for Pharmaceutical Treatment.<br>A influência do seguimento farmacoterapêutico (SFT) sobre a qualidade de vida foi avaliada em 45 pacientes HIV+ assistidos em serviço de atendimento especializado do nordeste brasileiro. O SFT teve duração de 9 meses e a qualidade de vida foi analisada no 1º e 9º encontros através de questionário validado no País. Identificaram-se 643 problemas relacionados aos antirretrovirais e realizaram-se 590 intervenções farmacêuticas durante o SFT. A análise comparativa entre os resultados de qualidade de vida do 1º e 9º encontro foi estatisticamente significativa em todos os domínios do questionário. Quando analisados somente os pacientes assintomáticos, apenas um domínio apresentou significância estatística. Entre os sintomáticos, seis domínios foram significativos. Pacientes com até um ano de diagnóstico de HIV/AIDS apresentaram validade estatística em cinco domínios. Os resultados sugerem que o SFT contribuiu para a melhoria da qualidade de vida dos pacientes, sobretudo dos sintomáticos e/ou com até um ano de diagnóstico, representando grupos-alvo para a prática da Atenção Farmacêutica. |
topic |
Seguimento farmacoterapêutico Seguimento farmacoterapêutico Paciente de HIV Atenção Farmacêutica Pharmacotherapeutic follow-up Pharmacotherapeutic follow-up HIV patients Pharmaceutical care |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400015 |
work_keys_str_mv |
AT catarinevitorloureiro qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT henrypablolopescamposereis qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT karladonascimentomagalhaes qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT cristianepolicarpocarmo qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT franciscaanamarialeite qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT anaclaudiadebritopassos qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT pauloyurimilenfirmino qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT nadirkheir qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT davidjohnwoods qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT angelamariadesouzaponciano qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup AT martamariadefrancafonteles qualityoflifeofhivpatientsundergoingpharmacotherapeuticfollowup |
_version_ |
1725508516665360384 |